Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alligator Bioscience AB (GB:0RK9)
:0RK9
0RK9 Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.23 - kr1.51
Previous CloseN/A
Volume0.00
Average Volume (3M)10.58K
Market Cap
kr10.72M
Enterprise Valuekr168.03M
Total Cash (Recent Filing)659.14M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.19
Shares Outstanding758,039,250
10 Day Avg. Volume14,228
30 Day Avg. Volume10,584
Standard Deviation0.32
R-Squared0.00505
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.83
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
0RK9 FAQ
What was Alligator Bioscience AB’s price range in the past 12 months?
Alligator Bioscience AB lowest share price was kr0.23 and its highest was kr1.51 in the past 12 months.
What is Alligator Bioscience AB’s market cap?
Alligator Bioscience AB’s market cap is kr10.72M.
When is Alligator Bioscience AB’s upcoming earnings report date?
Alligator Bioscience AB’s upcoming earnings report date is Apr 24, 2025 which is in 79 days.
How were Alligator Bioscience AB’s earnings last quarter?
Alligator Bioscience AB released its earnings results on Jan 22, 2025. The company reported -kr0.073 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.073.
Is Alligator Bioscience AB overvalued?
According to Wall Street analysts Alligator Bioscience AB’s price is currently Overvalued.
Does Alligator Bioscience AB pay dividends?
Alligator Bioscience AB does not currently pay dividends.
What is Alligator Bioscience AB’s EPS estimate?
Alligator Bioscience AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alligator Bioscience AB have?
Alligator Bioscience AB has 758,039,250 shares outstanding.
What happened to Alligator Bioscience AB’s price movement after its last earnings report?
Alligator Bioscience AB reported an EPS of -kr0.073 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alligator Bioscience AB?
Currently, no hedge funds are holding shares in GB:0RK9
---
Company Description
Alligator Bioscience AB
Alligator Bioscience AB is a biotech company, which engages in the development of innovative antibody- based medicines for immunotherapy of cancer. It specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company was founded by Carl Arne Krister Borrebaeck in 2001 and is headquartered in Lund, Sweden.
---
Technical Analysis
---